What are the recommended meningococcal vaccines for preteens and teens. How do meningococcal vaccines help prevent serious illness. When should teens and young adults get meningococcal vaccine boosters. What are the potential side effects of meningococcal vaccines.

Understanding Meningococcal Disease and Its Risks

Meningococcal disease is a rare but potentially devastating illness that can strike suddenly and progress rapidly. While it can affect people of all ages, teens and young adults are at increased risk. But what exactly is meningococcal disease, and why is it so dangerous?

Meningococcal disease is caused by bacteria that can lead to severe infections of the brain and spinal cord (meningitis) or bloodstream (bacteremia or septicemia). These infections can become life-threatening within hours of symptom onset. Even with prompt treatment, about 10-15% of people who contract meningococcal disease die. Among survivors, up to 20% may suffer permanent disabilities such as hearing loss, brain damage, or limb amputations.

The elevated risk for teens and young adults is due to several factors:

• Close contact in school and college settings
• Sharing of food, drinks, and personal items
• Changes in sleep patterns and immune system during adolescence
• Smoking and exposure to secondhand smoke

Given these risks, vaccination plays a crucial role in protecting this vulnerable age group.

Types of Meningococcal Vaccines Available

In the United States, two main types of meningococcal vaccines are licensed for use:

1. Meningococcal conjugate (MenACWY) vaccines
2. Serogroup B meningococcal (MenB) vaccines

These vaccines target different strains (serogroups) of the bacteria that cause meningococcal disease. MenACWY vaccines provide protection against serogroups A, C, W, and Y, while MenB vaccines protect against serogroup B. Currently, no single vaccine offers protection against all five serogroups.

Why are there different vaccines for different serogroups? The meningococcal bacteria have evolved distinct surface structures that require targeted vaccine approaches. By offering separate vaccines, medical professionals can tailor protection based on the most prevalent strains in a given region or population.

CDC Recommendations for Meningococcal Vaccination

The Centers for Disease Control and Prevention (CDC) has established clear guidelines for meningococcal vaccination to ensure optimal protection for teens and young adults. These recommendations are based on extensive research and epidemiological data.

MenACWY Vaccine Recommendations

For the MenACWY vaccine, the CDC recommends:

• A first dose for all preteens at 11 to 12 years old
• A booster dose for all teens at 16 years old

The booster dose at age 16 is crucial as it provides continued protection during the years when teens are at highest risk of meningococcal disease. If a teenager missed getting the MenACWY vaccine, they should consult their doctor about catching up on this important immunization.

MenB Vaccine Recommendations

For the MenB vaccine, the CDC states that teens and young adults aged 16 through 23 years may receive the vaccine, with a preference for ages 16 through 18 years. This vaccination is not routinely recommended for all teens but should be considered based on individual risk factors and in consultation with a healthcare provider.

Are there situations where younger children or adults might need meningococcal vaccines? While these vaccines are primarily recommended for adolescents, certain high-risk groups may require vaccination at other ages. These include individuals with specific medical conditions, those traveling to areas where the disease is common, laboratory workers who routinely work with meningococcal bacteria, and people at increased risk due to a local disease outbreak.

Importance of Meningococcal Booster Shots

Booster shots play a vital role in maintaining protection against meningococcal disease. But why are they necessary, and when should they be administered?

The initial dose of MenACWY vaccine given at 11-12 years old provides good short-term protection. However, studies have shown that antibody levels begin to wane after 3-5 years. This decline in immunity coincides with the period of highest risk for meningococcal disease in late adolescence.

To address this vulnerability, the CDC recommends a booster dose of MenACWY vaccine at age 16. This timing ensures that teens have robust protection during their highest risk years, typically extending through college age.

For individuals who received their first dose later than the recommended age, the following guidelines apply:

• If the first dose was given at 13-15 years old, the booster should be administered between 16-18 years of age
• If the first dose was given at 16 years or older, no booster is typically needed

By adhering to these booster recommendations, parents and healthcare providers can help ensure that teens maintain optimal protection against meningococcal disease throughout their most vulnerable years.

Safety and Side Effects of Meningococcal Vaccines

Meningococcal vaccines have been thoroughly studied and are generally considered safe. However, like all medical interventions, they can cause side effects. Understanding these potential reactions can help parents and teens make informed decisions and know what to expect after vaccination.

Common Side Effects of MenACWY Vaccines

Approximately half of the people who receive a MenACWY vaccine experience mild side effects, which typically include:

• Redness or pain at the injection site
• Low-grade fever

These reactions are usually short-lived, resolving on their own within 1 to 2 days.

Common Side Effects of MenB Vaccines

MenB vaccines tend to cause side effects in more than half of recipients. These may include:

• Soreness, redness, or swelling at the injection site
• Fatigue
• Headache
• Muscle or joint pain
• Fever or chills
• Nausea or diarrhea

These reactions typically improve within 3 to 7 days without intervention.

While serious reactions to meningococcal vaccines are possible, they are rare. The benefits of vaccination in preventing potentially life-threatening meningococcal disease generally outweigh the risks of vaccine side effects for most individuals.

Administering Meningococcal Vaccines: Timing and Considerations

Proper timing and administration of meningococcal vaccines are crucial for achieving optimal protection. How should these vaccines be given, and can they be administered alongside other immunizations?

MenACWY and MenB vaccines can be given during the same visit, typically in different arms. This approach is convenient and ensures timely protection against multiple strains of meningococcal bacteria. For the MenB vaccine, multiple doses are needed for best protection, and it’s important to use the same brand for all doses in the series.

When considering the MenB vaccine, the preferred age range is 16 through 18 years old. This timing often coincides with the MenACWY booster, allowing for efficient vaccination during a single healthcare visit.

Can meningococcal vaccines be given alongside other routine adolescent immunizations? Yes, these vaccines are safe to administer concurrently with other recommended vaccines such as Tdap (tetanus, diphtheria, pertussis), HPV (human papillomavirus), and influenza vaccines. This approach can streamline the vaccination process and improve overall compliance with immunization schedules.

Special Considerations for Meningococcal Vaccination

While meningococcal vaccination is routinely recommended for adolescents, certain groups may require special consideration. Who else should consider meningococcal vaccination, and under what circumstances?

Medical Conditions Warranting Vaccination

Some medical conditions can increase the risk of meningococcal disease. Individuals with the following conditions may need meningococcal vaccination, regardless of age:

• Complement component deficiencies
• Functional or anatomic asplenia
• HIV infection

Travel-Related Vaccination

People traveling to areas where meningococcal disease is more common, such as parts of sub-Saharan Africa, may need vaccination. This is particularly important for those planning extended stays or living in close contact with local populations.

Occupational Risk

Certain occupations carry an increased risk of exposure to meningococcal bacteria. Laboratory personnel who routinely work with Neisseria meningitidis should be vaccinated.

Outbreak Response

During localized outbreaks of meningococcal disease, public health officials may recommend vaccination for specific groups at increased risk. This could include students at a particular school or attendees of a large event.

In these special circumstances, healthcare providers may recommend vaccination schedules that differ from the routine adolescent recommendations. It’s important for individuals in these high-risk groups to consult with their doctor about appropriate meningococcal vaccination.

The Impact of Meningococcal Vaccination on Public Health

Meningococcal vaccination programs have had a significant impact on public health since their introduction. How have these vaccines changed the landscape of meningococcal disease in the United States?

Since the introduction of the MenACWY vaccine in 2005 and its widespread adoption, there has been a substantial decrease in meningococcal disease caused by serogroups C, W, and Y among adolescents and young adults. The incidence of these strains has declined by over 80% in this age group.

The more recent introduction of MenB vaccines in 2014-2015 has provided additional protection against serogroup B, which had become the leading cause of meningococcal disease in adolescents following the success of the MenACWY vaccine.

Despite these successes, meningococcal disease remains a public health concern due to its severity and potential for outbreaks. Continued vigilance and high vaccination rates are crucial for maintaining these public health gains.

What challenges remain in meningococcal disease prevention? While vaccination has dramatically reduced disease incidence, several challenges persist:

• Ensuring high vaccination coverage, particularly for booster doses
• Addressing vaccine hesitancy and misinformation
• Developing vaccines that provide broader and longer-lasting protection
• Monitoring for potential shifts in disease-causing strains

Ongoing research and public health efforts continue to address these challenges, aiming to further reduce the burden of meningococcal disease.

Educating Teens and Parents about Meningococcal Vaccination

Effective education is crucial for ensuring high meningococcal vaccination rates among teens. How can healthcare providers and public health officials best communicate the importance of these vaccines to teens and their parents?

Clear, accurate information about meningococcal disease and its potential consequences is essential. This should include:

• Explaining the rapid progression and severity of meningococcal infections
• Highlighting the increased risk for teens and young adults
• Discussing the safety and effectiveness of meningococcal vaccines
• Addressing common concerns and misconceptions about vaccination

Healthcare providers play a pivotal role in this education process. They should proactively discuss meningococcal vaccination during routine check-ups and offer strong recommendations based on individual risk factors.

What strategies can improve vaccine uptake among teens? Several approaches have shown promise:

• Leveraging social media and digital platforms to reach teens directly
• Incorporating peer education programs in schools
• Providing easy access to vaccination through school-based clinics
• Using reminder systems to ensure timely booster doses

By combining comprehensive education with accessible vaccination programs, public health officials can work towards optimal protection against meningococcal disease for all adolescents and young adults.

Meningococcal Vaccination | CDC

Español (Spanish)

Print

Teens and young adults are at increased risk for meningococcal disease. Meningococcal disease is a very serious illness where death can occur in as little as a few hours. Talk with a doctor about meningococcal vaccination to help protect your child’s health.

There are two types of meningococcal vaccines licensed in the United States:

• Meningococcal conjugate (MenACWY) vaccines
• Serogroup B meningococcal (MenB) vaccines

These vaccines help prevent the most common causes of meningococcal disease in the United States.

CDC recommends meningococcal vaccines for preteens, teens, and certain other people

CDC recommends MenACWY vaccine for:

• All preteens at 11 to 12 years old
• All teens at 16 years old

The booster dose at 16 years old gives teens continued protection during the ages when they are at highest risk.

If your teenager missed getting MenACWY vaccine, ask their doctor about getting it now.

Teens and young adults (16 through 23 year olds) may also get MenB vaccine:

• Preferred age is 16 through 18 years old
• Multiple doses needed for best protection
• Must get the same brand for all doses

Talk with your teen’s doctor if you are interested in MenB vaccination.

Younger children and adults usually do not need meningococcal vaccines. However, CDC recommends one or both types of meningococcal vaccines for people with

• Certain medical conditions
• Travel plans to areas where the disease is common
• Jobs working with the bacteria
• Increased risk due to a meningococcal disease outbreak

Learn more about who should get meningococcal vaccines.

Meningococcal vaccines are safe but side effects can occur

About half of people who get a MenACWY vaccine have mild problems following vaccination:

• Redness or pain where they got the shot
• Fever

These reactions usually get better on their own within 1 to 2 days, but serious reactions are possible.

Following MenB vaccination, more than half of people who get the vaccine will have mild problems:

• Soreness, redness, or swelling where they got the shot
• Fatigue (tiredness)
• Headache
• Muscle or joint pain
• Fever or chills
• Nausea or diarrhea

These reactions usually get better on their own within 3 to 7 days, but serious reactions are possible.

• Meningococcal Communication and Print Resources
• Meningococcal vaccination information
  • What everyone should know
  • Information for healthcare professionals
• Vaccination coverage: TeenVaxView for MenACWY Data
• Vaccination schedules (parent-friendly)
• Vaccines for Children program

Top of Page

Meningococcal Vaccination for Preteens and Teens: For Parents

• Meningococcal Vaccines
• MenACWY Vaccines
• MenB Vaccines

CDC recommends meningococcal vaccination for all preteens and teens. All 11 to 12 year olds should receive a single dose of a meningococcal conjugate (MenACWY) vaccine. Since protection decreases over time, CDC recommends a booster dose at age 16 years. The booster dose provides protection during the ages when teens are at highest risk of meningococcal disease. Teens and young adults (16 through 23 year olds) also may receive a serogroup B meningococcal (MenB) vaccine. The preferred age to get MenB vaccine is 16 through 18 years old. Talk with your teen’s doctor about meningococcal vaccination to help protect your child’s health.

Meningococcal Vaccines

Preteens and teens are at increased risk for meningococcal disease, an uncommon but serious illness.

Meningococcal disease can be devastating and often—and unexpectedly—strikes otherwise healthy people. Although meningococcal disease is uncommon, teens and young adults 16 through 23 years old are at increased risk. Meningococcal bacteria can cause severe, even deadly, infections like

• Meningitis (an infection of the lining of the brain and spinal cord)
• Bacteremia or septicemia (bloodstream infections)

About 1 in 5 people who survive their meningococcal infection have permanent disabilities.

There are 2 types of meningococcal vaccines available in the United States. Each type helps protect your child against different serogroups (strains) of meningococcal disease.

MenACWY vaccines provide protection against 4 serogroups: A, C, W, and Y. MenB vaccines provide protection against serogroup B. Currently no meningococcal vaccine offers protection against these 5 serogroups in 1 shot.

Your child can get MenACWY and MenB vaccines at the same time.

Your child’s doctor can give both types of meningococcal vaccines during the same visit, but preferably in different arms. If you choose for your child to get a MenB vaccine, the preferred timing is between 16 and 18 years old. So it’s possible your child will get this vaccine and the MenACWY booster dose at the same visit.

 Top of Page

MenACWY Vaccines

A MenACWY booster shot helps protect your teen during the ages they are at highest risk of meningococcal disease.

Protection from a single dose of MenACWY vaccine declines in most teens within 5 years. Teens need a booster dose at age 16 years to provide protection during the ages when they are at highest risk.

Many colleges require proof of MenACWY vaccination within 5 years before starting school.

Regardless of school requirements, CDC recommends a booster dose for all teens who received the first dose before their 16^th birthday. The booster dose provides the best protection during the ages when teens are at highest risk. Teens who receive their first MenACWY vaccine dose at or after age 16 years do not need a booster dose.

MenACWY vaccines are safe. However, as with any vaccine, side effects can occur.

About half of the people who get a MenACWY vaccine have mild problems following vaccination, such as:

• Redness where the shot was given
• Soreness where the shot was given
• Muscle pain
• Headache
• Feeling tired

If they occur, these reactions usually get better on their own within 1 to 2 days. Serious reactions are possible, but rare.

CDC continually monitors the safety of all vaccines, including MenACWY vaccines. For more information, view the Meningococcal ACWY Vaccine Information Statement.

It does not matter which brand of MenACWY vaccine your child receives.

CDC has no preference as to which brand (Menactra^®, Menveo^®, or MenQuadfi^®) of a MenACWY vaccine your child receives.

 Top of Page

MenB Vaccines

There are many ways to find a MenB vaccine provider near you.

Your child’s doctor may already have these vaccines in their office. College health centers or pharmacies may also have them available.

If you’re interested in having your child vaccinated with a MenB vaccine, talk to your child’s doctor.

CDC does not routinely recommend a MenB vaccine for all teens and young adults. However, all teens may get vaccinated, preferably at 16 to 18 years old.

Serogroup B meningococcal disease is relatively rare. Outbreaks have occurred at several U.S. colleges during the past decade. CDC’s current recommendation gives people access to MenB vaccines to help prevent this uncommon, but serious illness. However, doctors and parents should discuss the risk of the disease and weigh the risks and benefits of vaccination. Available data suggest these vaccines are safe and provide protection, but that protection decreases fairly quickly after vaccination.

MenB vaccines are safe. However, as with any vaccine, side effects can occur.

Available data suggest that MenB vaccines are safe. More than half of the people who get a MenB vaccine have mild problems following vaccination:

• Soreness, redness, or swelling where the shot was given
• Feeling tired (fatigue)
• Headache
• Muscle or joint pain
• Fever or chills
• Nausea or diarrhea

If they occur, these reactions usually get better on their own within 3 to 5 days. Serious reactions are possible, but rare.

Teens are more likely to have side effects after MenB vaccination compared to other vaccines given to preteens and teens. Those other vaccines include HPV, MenACWY, and Tdap vaccines.

CDC continually monitors the safety of all vaccines, including MenB vaccines. For more information, view the Serogroup B Meningococcal Vaccine Information Statement.

Most health insurance plans pay for MenB vaccination for teens and young adults.

Most health plans must cover CDC-recommended vaccines with no out-of-pocket costs if an in-network healthcare provider administers the vaccine. Check with your insurance provider for details on whether there is any cost to you for this vaccine.

The Vaccines for Children, or VFC, program provides vaccines for children 18 years old and younger who are

• Not insured
• Medicaid-eligible
• American Indian or Alaska Native

Parents can find a VFC provider by contacting their local health department. VFC will cover the cost of MenB vaccination for those

• 16 through 18 years old
• 10 through 18 years old at increased risk due to a medical condition
• 10 through 18 years old identified as being at increased risk due to a serogroup B meningococcal disease outbreak

It does not matter which brand of a MenB vaccine your child receives.

CDC has no preference as to which brand (Bexsero^® or Trumenba^®) of MenB vaccine your child receives. Both brands require multiple doses. People must get the same vaccine brand for all doses.

MenB vaccines are administered as a 2- or 3-dose series.

Both MenB vaccines require more than 1 dose for maximum protection.

 Top of Page

Meningococcal Vaccination of Adolescents: Information for Healthcare Professionals

Top of Page

Vaccination against meningococcal infection (Menactra) (single)

Vaccination of children and adults against meningococcal infection with Menactra® (Menactra).

Before vaccination, it is necessary to undergo a preventive examination by a doctor. Inspection is paid additionally.

Meningococcal disease is caused by the bacterium Neisseria meningitidis. Severe meningitis can cause deafness, mental disorders, paralysis, and disability. The only way to prevent severe forms of meningitis caused by Neisseria meningitidis is timely vaccination.

Menactra vaccine is designed to protect against infections caused by four groups of Neisseria meningitidis: A, C, W-135 and Y. The vaccine is non-live, consists of a solution of purified meningococcal polysaccharides coupled with diphtheria toxoid.

The vaccine is intended for infants from 9 months of age and adults up to 55 years of age.

Vaccine Efficacy

Menactra Adult and Children’s Vaccine is a safe, purified product that is developed to strict vaccine manufacturing and storage standards.

One of the main advantages of the Menactra vaccine is its comprehensive protection against several of the most common types of meningococcus at once. The ability of “Menactra” to induce the development of immunological memory after primary vaccination is confirmed by data from clinical studies in both children and adults. The formation of such an immune response significantly reduces the risk of meningococcal infection.

The effectiveness of the vaccine is determined by the presence of bactericidal antibodies. Studies have shown that more than 90% of those vaccinated form an adequate immune response against meningococcus 7-10 days after immunization. Immunity after vaccination lasts an average of 5 years.

Vaccination

Duration of vaccination depends on age:

• for children aged 9 months to 2 years, the course includes the introduction of 2 injections of 1 dose of vaccine (0.5 ml). The injection interval is at least 3 months.
• children from two years of age and adults the vaccine is administered once at a dose of 0.5 ml.

The site of administration of the vaccine is also chosen taking into account age:

• for children aged 9 to 12 months, the vaccine is administered in the anterolateral region of the thigh;
• children over 1 year old and adults – in the deltoid muscle of the shoulder.

Do not administer the vaccine subcutaneously or intravenously.

If the risk of meningococcal infection persists, a single revaccination can be carried out if at least 4 years have passed since the previous dose. In childhood and adolescence, revaccination is recommended in case of a sharp change in the team (change of educational institution, military service, living in a hostel, etc.).

Children and adults are examined by a pediatrician or general practitioner prior to vaccination to obtain approval for vaccination. This is necessary to exclude an acute illness or other contraindications. Thermometry is mandatory, as well as an objective examination of organs and systems.

Side effects

In rare cases, the vaccine may cause a number of adverse reactions. The nature and frequency of side effects identified in the studies varied depending on the age of the vaccinated.

Adverse reactions in children 9 to 18 months:

• Loss of appetite;
• Drowsiness;
• Vomiting;
• Diarrhea;
• Rash;
• Urticaria;
• Arthralgia;
• Soreness and induration at injection site;
• Irritability, redness at the injection site, swelling at the injection site, fever.

Adverse reactions in children aged 2 to 10 years:

• Decreased appetite;
• Drowsiness;
• Diarrhea;
• Vomiting;
• Rash, urticaria;
• Arthralgia;
• Soreness and induration at injection site;
• Irritability, redness at the injection site, swelling at the injection site, fever.

Adverse reactions in adolescents 11 to 18 years of age and adults over 18 years of age:

• Decreased appetite;
• Headache;
• Diarrhea;
• Vomiting;
• Rash;
• Arthralgia;
• Pain, induration, redness and swelling at the injection site, fatigue, general malaise;
• Chills, fever.

Special instructions

• In persons with impaired blood coagulation, the possible risks of bleeding should be assessed when administering the vaccine.
• People diagnosed with Guillain-Barré syndrome have an increased risk of exacerbation of the disease after the vaccine is given. The decision on the possibility of using the Menactra vaccine in this case is made by the doctor.
• The vaccine is not indicated for the prevention of meningitis caused by other bacteria and for the prevention of meningococcal disease caused by type B meningococci.
• Individuals who are immunocompromised may develop a reduced immune response after vaccine administration.

Pregnancy and lactation

Pregnant and lactating women should only be vaccinated if absolutely necessary: ​​ eg during a meningococcal outbreak or before traveling to an endemic area.

Obligatory consultation of the attending physician is required for admission to vaccination.

Interactions with other vaccines

• Menactra can be administered with any other vaccines from the National Immunization Schedule, except BCG (tuberculosis vaccine).
• Children who are splenic and HIV-infected should not receive Menactra vaccine at the same time as pneumococcal vaccine. Vaccination is carried out in different months to form adequate protection.
• When two or more vaccines are administered on the same day, the drugs are injected into different parts of the body with different syringes.

Indications for examination

Prevention of infections caused by Neisseria meningitidis groups A, C, Y and W-135 in people aged 9 months to 55 years.

In particular, the following groups are recommended to be vaccinated:

• children under 5 years old attending kindergarten;
• travelers and people who travel frequently on business trips;
• persons in contact with patients;
• people with immunodeficiency conditions;
• persons with chronic diseases of the spleen or its absence;
• medical workers and other persons who are in the focus of infection (children’s preschool institutions, barracks, hostels).

Examination preparation

No special preparation required.

ᐈ Menactra ~【Vaccination against meningococcal infection in Kyiv】

More
Collapse

online entry

Menactra is a meningococcal polysaccharide conjugate vaccine in combination with diphtheria toxoid. The Menactra vaccine (Kyiv, MEDICOM) will help to avoid purulent meningitis, sepsis, meningoencephalitis, multiple organ failure and other severe lesions caused by meningococcus and their consequences.

Vidkriti
Zgornuti

How can you get meningitis?

Meningococcal disease is caused by Neisseria meningitidis. Meningococcus is transmitted by aerosol or direct contact through the respiratory secretions of sick people, as well as from healthy carriers.

Infection can lead to both normal carriage and serious damage to vital organs. The purpose of the vaccine is to prevent diseases caused by meningococcus serogroups A, C, Y, and W-135, but does not protect against serogroup B.

Meningococcal carriers are common among adolescents and young adults. The transition from asymptomatic carriage to the disease occurs under the influence of a number of factors:

• bacterial virulence;
• states of immunity;
• connecting viral infection;
• changes in climatic conditions;
• dusty, etc.

Vidkriti
Zgornuti

What disease does Menactra protect against?

Meningococcal disease is an acute, severe infectious disease. Its causative agent is a bacterium with 13 serogroups.

Menactra vaccine protects against several meningococcal infections:

• nasopharyngitis;
• meningitis;
• meningoencephalitis;
• meningococcemia (or, as it is also called, meningococcal sepsis).

Meningococcus causes infection of the lungs, joints, respiratory tract, urinary tract, and eyes.

Vidkriti
Zgornuti

Meningococcal symptoms:

• increase in body temperature up to 37.5-38.0 ° C;
• sore throat;
• painful sensations when swallowing;
• headache;
• nasal congestion;
• lethargy;
• adynamia;
• decrease or loss of appetite.

Vidkriti
Zgornuti

The throat becomes edematous and hyperemic, sometimes there are convulsions, a specific rash, hemorrhagic elements of purple-red color with a bluish tint.

Despite early diagnosis and treatment, up to 15% of patients die within the first two days, and without treatment – up to 50%. After the disease, patients receive severe complications in the form of hearing loss, brain damage, mental disorders, paralysis, epileptic seizures. Significant tissue necrosis can lead to disability.

Vidkriti
Zgornuti

When should I get the Menactra vaccination?

Maternal antibodies to meningococcus, which are passively passed on to the child, protect only during the first months of life. At an older age, the child becomes completely defenseless against meningitis.

Menactra: indications

Meningitis vaccination is indicated for children from 9 months. and adults under 55. The main risk group for meningococcal infection is children under 5 years of age.

Worth getting vaccinated:

• children from 1.5 to 5 years old who go to preschool;
• persons who often go on business trips and travel a lot;
• for those who are undergoing a medical examination for a visa to the United States, as well as for travel abroad;
• persons in contact with the patient;
• immunocompromised persons;
• patients with disorders of the spleen / asplenia;
• to everyone who stays at the site of the outbreak in children’s groups, among students, conscripts, etc.

Vaccination against meningococcal infection is indicated for pregnant women only in situations of urgent need: due to an outbreak of meningitis, travel to dangerous areas, direct contact with a sick person, etc. In each case, the doctor makes his own decision about vaccination.

Vidkriti
Zgornuti

Menactra: contraindications

Contraindications for vaccination:

• acute infectious diseases;
• hypersensitivity to the active and excipients of the vaccine;
• exacerbation of chronic diseases.

Vidkriti
Zgornuti

How to prepare for the Menactra vaccination?

Preparation for vaccination “Menactra” includes a mandatory visit to a pediatrician or therapist, who study the anamnesis and vaccination card, analyze the possibility of complications and existing contraindications. After the examination, an infectious disease consultation may be recommended.

Vidkriti
Zgornuti

How is Menactra vaccination carried out (Kyiv, MEDICOM)?

The Menactra vaccine is given exclusively intramuscularly in a volume of 0.5 ml. It is important to take into account the age of the person who came for vaccination, the presence of contraindications and the possibility of complications.

For children under one year old, the Menactra vaccine is injected into the anterolateral part of the thigh, for everyone else – into the shoulder.

Vidkriti
Zgornuti

Menactra: vaccination schedule

Vaccinations are given according to the following scheme:

• age from 9 to 23 months. – the vaccine is administered twice by 0.5 ml with an interval of 3 (or more) months;
• age from 2 years to 55 years – the vaccine is administered once in a volume of 0.5 ml.

Meningococcal vaccine “Menactra” is combined with other vaccines in the vaccination schedule, except for tuberculosis vaccine. In this case, the drugs are injected into different parts of the body.

Vidkriti
Zgornuti

In children under 2 years of age, Menactra can be used in conjunction with other prophylactic vaccines against:

• Corey
• Chicken pox
• Mumps
• Rubella
• Pneumococcal infection
• Hepatitis A

Vidkriti
Zgornuti

“Menactra”: side effects

The nature and frequency of manifestation of adverse reactions depends on the age of the vaccinated. Infants up to a year old may experience slight sensitivity and soreness at the vaccination site, loss of appetite, frequent crying, and fever. In children from 2 to 10 years old with the listed manifestations, redness at the injection site, dyspeptic symptoms, irritability, drowsiness, loss of appetite, anorexia, rash can be observed.

The following side effects may also occur at any age:

• arthralgia;
• headache;
• irritability;
• pain, tenderness at injection site;
• diarrhea, vomiting;
• allergic dermatitis;
• weakness, malaise, fatigue;
• temperature increase.

Vidkriti
Zgornuti

Benefits of Menactra

This vaccine provides protection against A, C, Y and W meningococci. The Menactra vaccine for adults and children is a safe, chemically purified drug that minimizes the risk of adverse reactions and complications. The drug is being developed in strict accordance with the general technical limitations regarding the production and storage of the vaccine.

Menactra is vaccinated with a drug manufactured by the pharmaceutical company Sanofi Pasteur Inc. , USA, which is used in almost all countries of the world.

“Menactra” ensures the formation of stable immunity and cellular memory, preventing the development of meningitis over the next 5 years.

Vaccination “Menactra” not only protects against meningococcal infection, but also temporarily restores defects in the immune status of the vaccinated. This leads to a decrease in the frequency of exacerbations of comorbidities and the addition of respiratory infections.

Vidkriti
Zgornuti

Advantages of Menactra vaccination in MEDIKOM

Do not know where to get vaccinated against meningococcal infection in Kyiv? The best general practitioners, pediatricians and infectious disease specialists of our clinic are waiting for you.

Our advantages:

1. Highly qualified staff.
2. Convenient location of branches (Obolon and Pechersk districts).
3. Meningococcal vaccine is intended for vaccination of children and adults.
4. Adaptation of Sanofi Pasteur vaccination to the vaccination schedule.
5. Exceptionally positive reviews of our patients about the Menactra vaccination.
6. Compliance of the drug with all quality requirements.
7. Affordable cost of the vaccine.
8. Separate entrance to the clinic for vaccinations.

In our clinic you can also get vaccinated with Nimenrix, the Belgian equivalent of Menactra.

You can get acquainted with the conditions for the provision of vaccination services at link.

Vidkriti
Zgornuti

Vidkriti
Zgornuti

Doctors

Menactra vaccination can be done in Kyiv in a large medical center of the city – the MEDICOM clinic. Before vaccination with the Sanofi Pasteur meningococcal vaccine, the clients of our clinic undergo all the necessary examinations. You can find out more about the Menactra vaccine, the price of the drug, which meningococcal serotypes the vaccine protects against, and whether complications are possible by calling the numbers listed on the clinic’s website.

show more

The cost of vaccination “Menactra”

For services marked with an asterisk *, the regular customer discount of 10% and 15% does not apply.

Programs

More
Collapse

Procedures/Manipulations

More
Collapse

Certificates

Licenses and certificates

Reviews

03.12.2020 15:25

Olga Filimonova

Menaktra cannot be found in public hospitals now. Thanks to the clinic for being able to vaccinate you without any problems. Thanks for taking care of me!

08.10.2020 16:01

Vlada P

We were advised to vaccinate against meningitis by pediatrician T.G. Starunov. Thank you very much for what ocreme. Sposterіgaєmosya at the same doctor from the very people. Chuyny and miracle doctor. We suggest that you put all the chips at once, but, unfortunately, don’t have to go out. I am terribly afraid of Meningitus. I suddenly think that it’s impossible for me to dress again if I’m sick. About splitting: analyzes of the minimum (shelter) plus a look at the doctor. The chips were transferred painlessly, everything is fine. Thank you doctor and clinic!

08/15/2020 08:38

Tetyana Pichurina

Do not risk your health and the health of your children! Tim more, scho є clinics, where you can without problems splinting in meningitis! I know two have been ill with my ailment. For one, everything ended more or less normally, but for a friend, the girl is now alive with bewilderment.

29.06.2020 21:29

Elvira

Cleavage from meningitis caused synovia in 2 years and 9 months. Later, I called the clinic, found out that I had a vaccine and signed up for a consultation. Before the speech, in the family doctor’s clinic, she could not achieve anything, there were no vaccines, and that’s all. Pediatrician of the clinic Gancheva E.A. she lost only garni of hostility about herself. She looked at her son, twisted the chip card and gave permission for vaccination. There were no complications after the procedure. I will say one thing: do not risk the health of your children!

12.06.2020 15:45

Natalya Bondarenko

I had meningitis 20 years ago, when I was 15 years old. The disease was very difficult, accompanied by swelling of the brain. Worst pains. Doctors could not make a diagnosis for several days. Surprisingly, everything more or less worked out. I vaccinate my children strictly according to the calendar. I definitely consider it necessary to be vaccinated against meningitis and pneumococcal infection. I thank the clinic for the opportunity to keep my children healthy!

04/08/2020 19:17

Nika M

I have never risked the health of my children. I don’t understand anti-vaxxers at all. Despite the fact that Menactra is not included in the vaccination schedule, I believe that this is a life-saving vaccine. By the way, our pediatrician Yu.V. Lysak fully supported me. In this clinic, she began to be observed during pregnancy, so after the appearance of her daughter, she remained. Thanks to the clinic for the adequacy, availability of diagnostics, for the availability of various vaccinations.

02.03.2020 14:03

Olga Z

I never really thought about meningitis. Of course I knew that there was such a dangerous disease, but somewhere outside my life. Recently, a child died in the kindergarten where my daughter goes. Very quickly and unexpectedly, literally in a day. We were told that it was meningitis of some kind of rapid form. Parents called an ambulance late and they simply did not have time to do anything. That’s when I thought that the tragedy could have been avoided if my parents had been vaccinated against meningitis. Unfortunately, vaccination cannot be given in ordinary hospitals, as it is not included in the vaccination schedule. We turned to this clinic for a consultation and we were immediately booked for an appointment with Tymchuk N.V. After examining the child and a blood test, we were sent for vaccination. Everything is fast, simple and affordable.